These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 9337826

  • 21. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
    Selroos O, Halme M.
    Thorax; 1991 Dec; 46(12):891-4. PubMed ID: 1792636
    [Abstract] [Full Text] [Related]

  • 22. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
    Wales D, Makker H, Kane J, McDowell P, O'Driscoll BR.
    Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
    [Abstract] [Full Text] [Related]

  • 23. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [Abstract] [Full Text] [Related]

  • 24. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [Abstract] [Full Text] [Related]

  • 25. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 26. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma.
    Kuna P, Joubert JR, Greefhorst LA, Magnussen H.
    Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127
    [Abstract] [Full Text] [Related]

  • 27. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 28. Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma.
    Fitzgerald D, Van Asperen P, Mellis C, Honner M, Smith L, Ambler G.
    Thorax; 1998 Aug; 53(8):656-61. PubMed ID: 9828851
    [Abstract] [Full Text] [Related]

  • 29. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.
    Agertoft L, Pedersen S.
    Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238
    [Abstract] [Full Text] [Related]

  • 30. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 31. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation.
    De Benedictis FM, Del Giudice MM, Vetrella M, Tressanti F, Tronci A, Testi R, Dasic G, Flic12 Study Group.
    J Asthma; 2005 Jun; 42(5):331-6. PubMed ID: 16116682
    [Abstract] [Full Text] [Related]

  • 32. Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults.
    Wilson AM, Brewster HJ, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Nov; 102(5):751-6. PubMed ID: 9819291
    [Abstract] [Full Text] [Related]

  • 33. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
    Goldberg S, Einot T, Algur N, Schwartz S, Greenberg AC, Picard E, Virgilis D, Kerem E.
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
    [Abstract] [Full Text] [Related]

  • 34. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT, Milgrom H, Yoon YK, Levy AL, Matz P, Welch MJ, Cahn A, Collins DA, Kathman S, Mehta R, Su SF, Kunka RL.
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [Abstract] [Full Text] [Related]

  • 35. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study.
    Wolfe JD, Selner JC, Mendelson LM, Hampel F, Schaberg A.
    Clin Ther; 1996 Jan; 18(4):635-46. PubMed ID: 8879892
    [Abstract] [Full Text] [Related]

  • 36. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
    Wilson AM, Lipworth BJ.
    Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
    [Abstract] [Full Text] [Related]

  • 37. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 38. Fluticasone propionate in asthma: a long term dose comparison study.
    Verona E, Petrov D, Cserhati E, Hofman J, Geppe N, Medley H, Hughes S.
    Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
    [Abstract] [Full Text] [Related]

  • 39. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ.
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.